Respiratory syncytial virus (RSV) is a common viral infection affecting infants (~3.6 million total population) mainly under age 1 year easily treated with nebulizer therapy.
Nirsevimab RSV Raises Infant Mortality Concerns
Written by Dr Peter McCullough MD, MPH